Chapter/Section Purchase

1 Study Coverage
1.1 Urological Cancer Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Xofigo (radium Ra 223 dichloride)
1.2.3 Jevtana (cabazitaxel)
1.2.4 Inlyta (axitinib)
1.2.5 Votrient (pazopanib hydrochloride)
1.2.6 Sutent (sunitinib malate)
1.2.7 Zytiga (abiraterone acetate)
1.2.8 Xtandi (enzalutamide)
1.2.9 Opdivo (nivolumab)
1.2.10 Provenge (sipuleucel-T)
1.3 Market by Application
1.3.1 Global Urological Cancer Therapeutics Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Medical Research Laboratory
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Urological Cancer Therapeutics Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Urological Cancer Therapeutics Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Urological Cancer Therapeutics Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Urological Cancer Therapeutics Drugs Sales by Region
2.4.1 Global Urological Cancer Therapeutics Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Urological Cancer Therapeutics Drugs by Region (2023-2028)
2.5 Global Urological Cancer Therapeutics Drugs Revenue by Region
2.5.1 Global Urological Cancer Therapeutics Drugs Revenue by Region (2017-2022)
2.5.2 Global Urological Cancer Therapeutics Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Urological Cancer Therapeutics Drugs Sales by Manufacturers
3.1.1 Global Top Urological Cancer Therapeutics Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Urological Cancer Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Urological Cancer Therapeutics Drugs in 2021
3.2 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers
3.2.1 Global Urological Cancer Therapeutics Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Urological Cancer Therapeutics Drugs Revenue in 2021
3.3 Global Urological Cancer Therapeutics Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Urological Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Urological Cancer Therapeutics Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Urological Cancer Therapeutics Drugs Sales by Type
4.1.1 Global Urological Cancer Therapeutics Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Urological Cancer Therapeutics Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Urological Cancer Therapeutics Drugs Sales Market Share by Type (2017-2028)
4.2 Global Urological Cancer Therapeutics Drugs Revenue by Type
4.2.1 Global Urological Cancer Therapeutics Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Urological Cancer Therapeutics Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Urological Cancer Therapeutics Drugs Price by Type
4.3.1 Global Urological Cancer Therapeutics Drugs Price by Type (2017-2022)
4.3.2 Global Urological Cancer Therapeutics Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Urological Cancer Therapeutics Drugs Sales by Application
5.1.1 Global Urological Cancer Therapeutics Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Urological Cancer Therapeutics Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Urological Cancer Therapeutics Drugs Sales Market Share by Application (2017-2028)
5.2 Global Urological Cancer Therapeutics Drugs Revenue by Application
5.2.1 Global Urological Cancer Therapeutics Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Urological Cancer Therapeutics Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Urological Cancer Therapeutics Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Urological Cancer Therapeutics Drugs Price by Application
5.3.1 Global Urological Cancer Therapeutics Drugs Price by Application (2017-2022)
5.3.2 Global Urological Cancer Therapeutics Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Urological Cancer Therapeutics Drugs Market Size by Type
6.1.1 North America Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
6.1.2 North America Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
6.2 North America Urological Cancer Therapeutics Drugs Market Size by Application
6.2.1 North America Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
6.2.2 North America Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
6.3 North America Urological Cancer Therapeutics Drugs Market Size by Country
6.3.1 North America Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
6.3.2 North America Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Urological Cancer Therapeutics Drugs Market Size by Type
7.1.1 Europe Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
7.1.2 Europe Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
7.2 Europe Urological Cancer Therapeutics Drugs Market Size by Application
7.2.1 Europe Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
7.2.2 Europe Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
7.3 Europe Urological Cancer Therapeutics Drugs Market Size by Country
7.3.1 Europe Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
7.3.2 Europe Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Urological Cancer Therapeutics Drugs Market Size by Type
8.1.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Urological Cancer Therapeutics Drugs Market Size by Application
8.2.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Urological Cancer Therapeutics Drugs Market Size by Region
8.3.1 Asia Pacific Urological Cancer Therapeutics Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Urological Cancer Therapeutics Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Urological Cancer Therapeutics Drugs Market Size by Type
9.1.1 Latin America Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
9.1.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
9.2 Latin America Urological Cancer Therapeutics Drugs Market Size by Application
9.2.1 Latin America Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
9.2.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
9.3 Latin America Urological Cancer Therapeutics Drugs Market Size by Country
9.3.1 Latin America Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
9.3.2 Latin America Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size by Type
10.1.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size by Application
10.2.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Urological Cancer Therapeutics Drugs Market Size by Country
10.3.1 Middle East and Africa Urological Cancer Therapeutics Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Urological Cancer Therapeutics Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Novartis Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Pfizer Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Overview
11.4.3 AstraZeneca Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 AstraZeneca Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 AstraZeneca Recent Developments
11.5 Astellas
11.5.1 Astellas Corporation Information
11.5.2 Astellas Overview
11.5.3 Astellas Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Astellas Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Astellas Recent Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Corporation Information
11.6.2 Bristol-Myers Squibb Overview
11.6.3 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Bristol-Myers Squibb Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb Recent Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Corporation Information
11.7.2 Abbott Laboratories Overview
11.7.3 Abbott Laboratories Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Abbott Laboratories Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Abbott Laboratories Recent Developments
11.8 Celgene Corporation
11.8.1 Celgene Corporation Corporation Information
11.8.2 Celgene Corporation Overview
11.8.3 Celgene Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Celgene Corporation Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Celgene Corporation Recent Developments
11.9 Dendreon Corporation
11.9.1 Dendreon Corporation Corporation Information
11.9.2 Dendreon Corporation Overview
11.9.3 Dendreon Corporation Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Dendreon Corporation Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Dendreon Corporation Recent Developments
11.10 Ferring Pharmaceuticals
11.10.1 Ferring Pharmaceuticals Corporation Information
11.10.2 Ferring Pharmaceuticals Overview
11.10.3 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ferring Pharmaceuticals Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ferring Pharmaceuticals Recent Developments
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Corporation Information
11.11.2 GlaxoSmithKline plc Overview
11.11.3 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 GlaxoSmithKline plc Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 GlaxoSmithKline plc Recent Developments
11.12 Indevus Pharmaceuticals Inc
11.12.1 Indevus Pharmaceuticals Inc Corporation Information
11.12.2 Indevus Pharmaceuticals Inc Overview
11.12.3 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Indevus Pharmaceuticals Inc Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Indevus Pharmaceuticals Inc Recent Developments
11.13 Ipsen
11.13.1 Ipsen Corporation Information
11.13.2 Ipsen Overview
11.13.3 Ipsen Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Ipsen Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Ipsen Recent Developments
11.14 Roche Healthcare
11.14.1 Roche Healthcare Corporation Information
11.14.2 Roche Healthcare Overview
11.14.3 Roche Healthcare Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Roche Healthcare Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Roche Healthcare Recent Developments
11.15 Sanofi S.A.
11.15.1 Sanofi S.A. Corporation Information
11.15.2 Sanofi S.A. Overview
11.15.3 Sanofi S.A. Urological Cancer Therapeutics Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Sanofi S.A. Urological Cancer Therapeutics Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Sanofi S.A. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Urological Cancer Therapeutics Drugs Industry Chain Analysis
12.2 Urological Cancer Therapeutics Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urological Cancer Therapeutics Drugs Production Mode & Process
12.4 Urological Cancer Therapeutics Drugs Sales and Marketing
12.4.1 Urological Cancer Therapeutics Drugs Sales Channels
12.4.2 Urological Cancer Therapeutics Drugs Distributors
12.5 Urological Cancer Therapeutics Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Urological Cancer Therapeutics Drugs Industry Trends
13.2 Urological Cancer Therapeutics Drugs Market Drivers
13.3 Urological Cancer Therapeutics Drugs Market Challenges
13.4 Urological Cancer Therapeutics Drugs Market Restraints
14 Key Findings in The Global Urological Cancer Therapeutics Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer